Navigation Links
Global Pipettes and Pipettors Market to Reach $996.2 Million by 2012, According to New Report by Global Industry Analysts, Inc.
Date:11/10/2008

Breakthroughs in the human genome project coupled with phenomenal growth in large-scale applications such as combinatorial chemistry is expected to fuel demand for standard as well as highly specialized laboratory equipment. Global Pipettes and Pipettors market is projected to reach $996.2 million by 2012.

San Jose, CA (PRWEB) November 10, 2008 -- Pipettes and pipettors are treated as an integral part of any research laboratory. Large-scale applications in life sciences and biomedical research continue to drive the use of advanced pipettes and pipettors. With increase in diagnostic tests and biotech research, pipetting has become a more frequent process in laboratories worldwide. Currently, protein research is in the limelight, following successful sequencing of human genome and improvements in protein research technology. New products now incorporate automation features, resist contamination, handle corrosive and hazardous fluids, and are usable for repetitive procedures. The trend towards miniaturization of liquid handling capabilities has led to fully integrated, multiple-application equipment with a wide range of functionality and customization.

As stated by the recent report published by Global Industry Analysts Inc., worldwide pipettes and pipettors market is dominated by Europe and United States, which together account for 60.3% share of dollar sales estimated in the year 2008. Asia-Pacific, the next largest regional market for pipettes and pipettors is expected to offer the strongest growth opportunity flaunting the potential to grow at a projected CAGR of about 5.7% over the years 2011 through 2015. The rising emphasis laid by developing countries on technology intensive areas such as biotechnology, pharmaceuticals,
'/>"/>

Source: PRWeb
Copyright©2008 Vocus, Inc.
All rights reserved  

0

GOOD

Page: 1 2 3

Related medicine news :

1. World Laboratory Washing Machines Market to Reach $84.9 Million by 2012, According to New Report by Global Industry Analysts
2. Obama Could Inherit Weaker Global Health Fund
3. U.S. Preventive Medicine(R) Awards Inaugural Global Prevention Prize to Dr. Valentin Fuster of Mount Sinai Heart
4. HMS Holdings Corp. to Present at Credit Suisse Annual Global Healthcare Conference
5. 5th Annual Global Conference on Stem Cell Therapy to be held Jan. 13-16, 2009 in NYC
6. Hi-Tech Advances the Practice of Minimally Invasive Gynecology at AAGL Global Congress
7. Global Med Technologies(R), Inc.s Inlog Subsidiary Licenses Its Leading Laboratory Information System to Gabriel Martin Hospital of Saint-Paul de la Reunion
8. Global AIDS Alliance Welcomes Election of Barack Obama
9. MCG receives $100,000 Grand Challenges Explorations grant for innovative global health research
10. ATS Medical to Participate at the Rodman & Renshaw Annual Global Investment Conference
11. CuraGen to Present at the Rodman & Renshaw Annual Global Investment Conference
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Global Pipettes and Pipettors Market to Reach $996.2 Million by 2012, According to New Report by Global Industry Analysts, Inc.
(Date:8/1/2014)... 2014 The Judicial Panel on Multidistrict ... replacement therapy caused strokes, heart attacks, and other injuries ... Matthew F. Kennelly as the transferee judge and ordered ... Chicago-based federal court. , As one of his first ... committees of attorneys who will move the litigation forward ...
(Date:8/1/2014)... New research at Washington University School of Medicine in ... often in males and frequently are more harmful than ... common malignant brain tumors, are diagnosed twice as often ... and do not survive as long. , The researchers ... reduce cancer risk, is significantly less active in male ...
(Date:8/1/2014)... New York (PRWEB) August 01, 2014 ... protecting the rights of victims injured by defective medical ... it would be recalling its Ethicon surgical power morcellator ... device maker sited concerns involving the spread of cancer ... report dated July 31, 2014. , Johnson ...
(Date:8/1/2014)... York, New York (PRWEB) August 01, 2014 ... filed in the wake of the 2012 Rejuvenate ... to move forward in New Jersey’s Bergen County ... documents filed in the proceeding, the Court has ... of Confidentiality governing any and all hard copy ...
(Date:8/1/2014)... Aug. 1, 2014 (HealthDay News) -- Almost 140 ... school transportation in the United States. But ... bus-related catastrophes, Dawne Gardner, injury prevention coordinator at ... Center, said in a medical center news release. ... returning to school, it,s important for parents and ...
Breaking Medicine News(10 mins):Health News:Judge Kennelly Appoints Attorney Michelle Kranz to the Plaintiffs’ Executive Committee in the Testosterone Replacement Therapy MDL 2Health News:Study reveals one reason brain tumors are more common in men 2Health News:J&J's Ethicon Unit Recalls its Power Morcellator Devices After Warnings by Federal Regulators and Concern About Risk of Spreading Occult Cancer, Parker Waichman Comments 2Health News:J&J's Ethicon Unit Recalls its Power Morcellator Devices After Warnings by Federal Regulators and Concern About Risk of Spreading Occult Cancer, Parker Waichman Comments 3Health News:J&J's Ethicon Unit Recalls its Power Morcellator Devices After Warnings by Federal Regulators and Concern About Risk of Spreading Occult Cancer, Parker Waichman Comments 4Health News:Stryker Hip Lawsuit News: New Order Issued in New Jersey Stryker Hip Recall Litigation, Bernstein Liebhard LLP Reports 2Health News:Stryker Hip Lawsuit News: New Order Issued in New Jersey Stryker Hip Recall Litigation, Bernstein Liebhard LLP Reports 3Health News:Expert Offers School Bus Safety Tips 2
... Preserves Competition for Medicare Advantage,Plans Sold to Senior ... of,Justice announced today that it will require UnitedHealth ... to divest assets relating,to United,s Medicare Advantage business ... with United,s acquisition of Sierra. The Department said ...
... An article co-authored by Susan L. Mitchell, M.D., ... reports that nursing home residents with advanced dementia ... two weeks before death. This practice raises concerns ... with advanced dementia, as well as the emergence ...
... place burden on Medicare, analysis finds , , MONDAY, Feb. ... Americans newly diagnosed with heart failure has declined, the ... new research finds. , The Duke University study analyzed ... diagnosed with heart failure between 1994 and 2003. It ...
... Combined hormone therapy appears to increase the risk that ... it may decrease the effectiveness of both methods for ... Feb. 25 issue of Archives of Internal Medicine, one ... Ph.D., a lead investigator at the Los Angeles Biomedical ...
... 20 percent of patients taking aspirin to lower the ... have an antiplatelet response from aspirin, the effect thought ... at Buffalo have shown. , Millions of people ... stroke, second heart attack or second episode of peripheral ...
... a Systems Biology company focussed on high quality annotation ... its abilities in the analysis of data generated by ... et al published in the January 2008 issue of ... Open Chromatin across the Genome where they identified DNase ...
Cached Medicine News:Health News:Justice Department Requires Divestiture in UnitedHealth Group's Acquisition of Sierra Health Services 2Health News:Justice Department Requires Divestiture in UnitedHealth Group's Acquisition of Sierra Health Services 3Health News:Hebrew SeniorLife researcher finds 2Health News:Hebrew SeniorLife researcher finds 3Health News:More Elderly Americans Living With Heart Failure 2Health News:LA BioMed study finds hormone therapy increases frequency of abnormal mammograms, breast biopsies 2Health News:Many stroke, heart attack patients may not benefit from aspirin 2Health News:Many stroke, heart attack patients may not benefit from aspirin 3Health News:Genomatix integrates genome-wide open chromatin from next generation sequencing 2
(Date:8/1/2014)... Aug. 1, 2014  NxStage Medical, Inc. (Nasdaq: ... announced that Jeffrey H. Burbank , Chief Executive Officer, ... at the 34 th Annual Canaccord Genuity Growth Conference ... , on Wednesday, August 13 th at 4:30 ... available at http://ir.nxstage.com/ .  About NxStage ...
(Date:8/1/2014)... HYDERABAD, India , Aug. 1, 2014 /PRNewswire/ ... manufacturer providing active pharmaceutical ingredients (APIs), ... to customers located in 85 countries, today announced ... year (FY) 2015, ended June 30, 2014. ... affected by work flow re-prioritization to accommodate certain ...
(Date:8/1/2014)... JUPITER, Fla. , Aug. 1, 2014 ... company whose patented and proprietary technologies are used to ... the bioenergy, bio-based chemical, biopharmaceutical and industrial enzyme industries, ... for the second quarter ended June 30, 2014 after ... host a conference call that day at 5:00 p.m. ...
Breaking Medicine Technology:NxStage to Present at the 34th Annual Canaccord Genuity Growth Conference 2Neuland Labs Reports First Quarter Fiscal Year 2015 Financial Results 2Neuland Labs Reports First Quarter Fiscal Year 2015 Financial Results 3Dyadic International To Announce Second Quarter 2014 Financial Results And Host Conference Call On Thursday, August 14, 2014 2Dyadic International To Announce Second Quarter 2014 Financial Results And Host Conference Call On Thursday, August 14, 2014 3
... UNION CITY, Calif., Sept. 9, 2011 Abaxis, Inc. ... analysis systems, announced today that Clint Severson, chairman and ... Annual Best Ideas Conference 2011 on Wednesday, September 14, ... held at The Omni Berkshire Place Hotel in New ...
... Inc. (" Valeant ") (NYSE/TSX:VRX), announced today that Valeant mailed ... ") its offer and take-over bid circular in connection with ... all of the outstanding common shares of Afexa (the " ... per Common Share. The Offer expires at 5:00p.m. ...
Cached Medicine Technology:Abaxis, Inc. to Present at CL King's 9th Annual Best Ideas Conference 2011 2Valeant Pharmaceuticals Announces Mailing of Offer and Take-Over Bid Circular to Shareholders of Afexa 2Valeant Pharmaceuticals Announces Mailing of Offer and Take-Over Bid Circular to Shareholders of Afexa 3Valeant Pharmaceuticals Announces Mailing of Offer and Take-Over Bid Circular to Shareholders of Afexa 4
POLYSORB™ sutures are composed of LACTOMER™ glycolide/lactide copolymer which is a synthetic polyester composed of glycolide and lactide (derived from glycolic and lactic acids)....
Surgitie&trade Single Use Ligating Loops with Delivery System...
ENDO SLIDE™ single use knot pusher with 12 units per box....
ENDO STITCH™ Single Use Loading Units....
Medicine Products: